COM:KRAIGLABS
Kraig Biocraft Laboratories, Inc.
- Stock
Last Close
0.09
21/11 17:24
Market Cap
141.22M
Beta: -
Volume Today
208.50K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 127 - | 124.50 1.97% | -2.50 102.01% | 3.29K - | 3.44B 104,620,060.79% | |||||||
average payables | 886.57K - | 1.57M 77.32% | 1.92M 22.03% | 2.38M 24.21% | 2.99M 25.36% | 3.74M 25.34% | 4.42M 18.18% | 5.05M 14.23% | 5.62M 11.14% | 3.19M 43.28% | 270.17K 91.52% | |
average receivables | 3.10K - | 15.93K - | 28.86K 81.21% | 12.94K 55.18% | -0.00 - | |||||||
book value per share | -0.00 - | -0.00 5.09% | -0.00 49.50% | -0.00 14.68% | -0.00 34.48% | -0.01 27.97% | -0.01 18.12% | -0.01 20.12% | -0.01 22.10% | -0.00 40.10% | ||
capex per share | -0.00 - | -0.00 1,019.81% | -0.00 9.23% | -0.00 94.16% | -0.00 1,078.12% | -0.00 64.41% | -0.00 760.72% | -0.00 - | -0.00 95.34% | |||
capex to depreciation | -0.59 - | -5.84 890.01% | -2.55 56.37% | -0.15 94.25% | -1.54 947.91% | -0.43 72.01% | -3.27 661.76% | -3.72 - | -0.18 95.19% | |||
capex to operating cash flow | 0.00 - | 0.05 964.78% | 0.04 12.15% | 0.00 93.94% | 0.04 1,637.43% | 0.05 14.03% | 0.09 90.19% | 0.05 - | 0.00 95.07% | |||
capex to revenue | -0.08 - | -0.32 310.08% | -0.03 91.10% | |||||||||
cash per share | 0.00 - | 0.00 55.91% | 0.00 53.52% | 0.00 15.62% | 0.00 94.29% | 0.00 26.89% | 0.00 792.34% | 0.00 543.34% | 0.00 178.78% | 0.00 47.74% | ||
days of inventory on hand | -0.00 - | |||||||||||
days payables outstanding | 0.12 - | 0.13 13.54% | 0.12 11.54% | 0.15 29.72% | 0.58 283.72% | |||||||
days sales outstanding | 365 - | 97.04 73.41% | ||||||||||
debt to assets | 0.01 - | 0.13 - | 0.70 436.12% | 4.51 545.61% | 1.82 59.63% | 1.87 2.44% | 0.80 57.07% | 0.39 51.59% | 0.03 92.33% | |||
debt to equity | -0.00 - | -0.02 - | -0.02 11.89% | -0.07 204.71% | -0.25 251.40% | -0.36 42.84% | -0.46 26.08% | -0.50 10.11% | -0.02 96.65% | |||
dividend yield | ||||||||||||
earnings yield | -0.23 - | -0.06 72.73% | -0.12 95.88% | -0.08 37.97% | -0.07 12.21% | -0.03 56.91% | -0.02 32.25% | -0.05 154.24% | -0.12 146.50% | -0.18 48.52% | ||
enterprise value | 31.76M - | 28.99M 8.73% | 16.91M 41.67% | 39.57M 134.04% | 34.49M 12.85% | 40.34M 16.96% | 163.18M 304.56% | 108.07M 33.77% | 70.27M 34.97% | 28.11M 60.00% | -2.46T 8,735,137.44% | |
enterprise value over ebitda | -13.96 - | -15.86 13.62% | -8.29 47.73% | -13.51 62.95% | -16.15 19.51% | -43.22 167.63% | -63.13 46.08% | -23.72 62.43% | -9.45 60.16% | -8.77 7.17% | 0.94 110.71% | |
ev to operating cash flow | -39.69 - | -32.04 19.26% | -17.47 45.47% | -39.11 123.80% | -47.27 20.88% | -171.64 263.07% | -150.00 12.61% | -86.13 42.58% | -39.02 54.69% | -14.90 61.83% | ||
ev to sales | 1.24K - | 354.38 71.47% | 100.43 71.66% | |||||||||
free cash flow per share | -0.00 - | -0.00 9.55% | -0.00 2.77% | -0.00 7.17% | -0.00 29.47% | -0.00 68.61% | -0.00 371.51% | -0.00 3.93% | -0.00 46.28% | -0.00 10.20% | ||
free cash flow yield | -0.03 - | -0.03 28.02% | -0.06 82.93% | -0.03 56.62% | -0.02 13.25% | -0.01 72.14% | -0.01 19.22% | -0.01 60.49% | -0.03 129.47% | -0.06 131.75% | ||
graham net net | -0.00 - | -0.00 2.95% | -0.00 49.37% | -0.00 13.63% | -0.00 34.09% | -0.01 26.74% | -0.01 30.16% | -0.01 15.16% | -0.01 18.03% | -0.00 36.15% | ||
graham number | 0.02 - | 0.01 52.94% | 0.01 28.26% | 0.02 23.38% | 0.02 2.02% | 0.01 21.18% | 0.02 77.91% | 0.03 40.63% | 0.04 10.64% | 0.02 41.28% | ||
income quality | 0.11 - | 0.48 350.73% | 0.45 6.11% | 0.33 27.41% | 0.31 5.01% | 0.20 35.71% | 0.37 85.97% | 0.25 32.49% | 0.22 11.32% | 0.49 119.46% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -26.48 - | -20.23 23.58% | -21.13 4.42% | -12.17 42.38% | -4.19 65.56% | -8.91 112.44% | -11.73 31.66% | -4.18 64.37% | -3.48 16.65% | 5.40 254.92% | ||
interest debt per share | 0.00 - | 0.00 1,518.99% | 0.00 41.58% | 0.00 71.90% | 0.00 27.65% | 0.00 107.61% | 0.00 194.82% | 0.00 64.10% | 0.00 7.57% | 0.00 30.37% | ||
inventory turnover | -2.11B - | |||||||||||
invested capital | -0.00 - | -0.02 - | -0.02 11.89% | -0.07 204.71% | -0.25 251.40% | -0.36 42.84% | -0.46 26.08% | -0.50 10.11% | -0.02 96.65% | |||
market cap | 32.05M - | 29.48M 8.01% | 17.15M 41.84% | 39.82M 132.24% | 34.43M 13.55% | 40.03M 16.27% | 161.94M 304.57% | 106.51M 34.23% | 70.21M 34.08% | 30.20M 56.98% | ||
net current asset value | -1.22M - | -1.27M 4.39% | -1.96M 54.71% | -2.41M 22.89% | -3.44M 42.67% | -4.51M 31.04% | -5.98M 32.64% | -7.03M 17.54% | -5.95M 15.36% | -4.11M 30.95% | -6.37T 154,924,037.43% | |
net debt to ebitda | 0.13 - | 0.27 111.47% | 0.12 56.89% | 0.08 27.25% | -0.03 134.08% | -0.33 1,040.65% | -0.48 45.49% | -0.34 28.50% | -0.01 97.45% | 0.65 7,553.62% | 0.94 43.97% | |
net income per share | -0.01 - | -0.00 76.67% | -0.00 10.05% | -0.00 32.74% | -0.00 28.62% | -0.00 51.46% | -0.00 167.96% | -0.01 64.64% | -0.01 57.13% | -0.01 42.45% | ||
operating cash flow per share | -0.00 - | -0.00 5.17% | -0.00 3.32% | -0.00 3.64% | -0.00 32.19% | -0.00 68.79% | -0.00 352.55% | -0.00 13.56% | -0.00 38.79% | -0.00 5.60% | ||
payables turnover | 3.16K - | 2.78K 11.93% | 3.14K 13.05% | 2.42K 22.91% | 631.48 73.94% | |||||||
receivables turnover | 1 - | 3.76 276.15% | ||||||||||
research and ddevelopement to revenue | 12.47 - | 2.66 78.66% | 0.37 86.14% | |||||||||
return on tangible assets | -24.00 - | -3.47 85.52% | -7.00 101.46% | -8.01 14.50% | -20.38 154.33% | -16.38 19.63% | -4.27 73.94% | -4.19 1.70% | -2.88 31.32% | -1.22 57.76% | -0.94 22.99% | |
revenue per share | 0.00 - | 0.00 187.29% | 0.00 299.82% | |||||||||
roe | 6.22 - | 1.53 75.42% | 1.12 26.39% | 1.30 15.75% | 0.69 46.92% | 0.26 62.07% | 0.59 126.85% | 0.82 37.06% | 1.64 101.70% | 1.58 3.92% | 0.53 66.39% | |
roic | 1.90 - | 1.55 18.51% | 1.13 26.89% | 1.33 17.44% | 0.65 50.91% | 0.24 63.93% | 0.82 245.52% | 1.28 57.26% | 1.08 15.96% | 1.82 68.68% | 0.47 73.91% | |
sales general and administrative to revenue | 80.99 - | 20.49 74.70% | 3.02 85.26% | |||||||||
shareholders equity per share | -0.00 - | -0.00 5.09% | -0.00 49.50% | -0.00 14.68% | -0.00 34.48% | -0.01 27.97% | -0.01 18.12% | -0.01 20.12% | -0.01 22.10% | -0.00 40.10% | ||
stock based compensation to revenue | 1.03 - | |||||||||||
tangible asset value | -1.20M - | -1.23M 2.02% | -1.90M 54.77% | -2.36M 24.45% | -3.38M 42.99% | -4.46M 32.09% | -5.39M 20.83% | -6.57M 22.00% | -5.30M 19.44% | -3.52M 33.50% | -5.71T 162,049,385.22% | |
tangible book value per share | -0.00 - | -0.00 5.09% | -0.00 49.50% | -0.00 14.68% | -0.00 34.48% | -0.01 27.97% | -0.01 18.12% | -0.01 20.12% | -0.01 22.10% | -0.00 40.10% | ||
working capital | -1.22M - | -1.27M 4.39% | -1.96M 54.71% | -2.41M 22.89% | -3.44M 42.67% | -4.51M 31.04% | -5.43M 20.34% | -6.63M 22.18% | -5.80M 12.59% | -4.09M 29.46% | -6.31T 154,378,542.10% |
All numbers in (except ratios and percentages)